Purdue, Mark P.
National Cancer Institute (NCI),
United States
2024 Rank: 75095
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 3061 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75095 | 73149 |
| Total Cites | 18267 | 21948 |
| H-index | 63 | 74 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 1895 | 2236 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 2887 | 3376 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15465 | 17392 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.26 |
| Self-Citation Percentage |
16.77%
|
|
Purdue, Mark P.
National Cancer Institute (NCI),
United States
2023 Rank: 75382
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 3106 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75382 | 73494 |
| Total Cites | 16172 | 19582 |
| H-index | 62 | 72 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 1824 | 2151 |
| Number of Single+First+Last Authored Papers | 91 | 91 |
| Total Cites to Single+First+Last Authored Papers | 2693 | 3159 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13659 | 15441 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.27 |
| Self-Citation Percentage |
17.41%
|
|
Purdue, Mark P.
National Cancer Institute (NCI),
2021 Rank: 79026
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 3236 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79026 | 74288 |
| Total Cites | 12918 | 15944 |
| H-index | 56 | 66 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 27 | 27 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 1652 | 1967 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 2345 | 2785 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10906 | 12483 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.28 |
| Self-Citation Percentage |
18.98%
|
|
Purdue, Mark P.
National Cancer Institute,
United States
2020 Rank: 84622
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 223 out of 9540 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84622 | 80017 |
| Total Cites | 10473 | 13093 |
| H-index | 50 | 60 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1527 | 1828 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 2083 | 2492 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8829 | 10198 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.28 |
| Self-Citation Percentage |
20.01%
|
|